Spurious elevation of serum thyrotropin (TSH) after OKT3 administration.
Goffin
E
E
Department of Nephrology, Cliniques Universitaires St-Luc, Brussels, Belgium.
Lambert
M
M
De Nayer
P
P
Saint-Remy
J M
JM
Pirson
Y
Y
van Ypersele de Strihou
C
C
D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D000910:Antibodies, Heterophile / Q000097:blood; D005189:False Positive Reactions; D006084:Graft Rejection / Q000097:blood / Q000628:therapy*; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis; D016030:Kidney Transplantation; D008297:Male; D016853:Muromonab-CD3 / Q000276:immunology* / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood*
D000888:Antibodies, Anti-Idiotypic; D000910:Antibodies, Heterophile; D016853:Muromonab-CD3; D013972:Thyrotropin